Copyright
©The Author(s) 2021.
World J Gastroenterol. Sep 28, 2021; 27(36): 6064-6078
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6064
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6064
Figure 5 Glutathione S-transferase mu 5 is a target of miRNA-20b-3p.
A and B: Expression of glutathione S-transferase mu 5 (GSTM5) after transfecting miRNA-20b-3p (miR-20b-3p) mimic; C and D: Expression of GSTM5 after transfecting circRNA_0084927 (circ_0084927); E and F: Expression of GSTM5 after transfecting sh-circ_0084927 plasmid and miR-20b-3p inhibitor; G: Overall survival by GSTM5 expression. Data are presented as the mean ± SEM. aP < 0.05, bP < 0.01. NC mimic: Negative control mimic; GSTM5: Glutathione S-transferase mu 5; miR-20b-3p: miRNA-20b-3p; Sh-circ_0084927: Short hairpin circ_0084927 plasmid; Sh-NC: Short hairpin negative control plasmid.
- Citation: Liu F, Xiao XL, Liu YJ, Xu RH, Zhou WJ, Xu HC, Zhao AG, Xu YX, Dang YQ, Ji G. CircRNA_0084927 promotes colorectal cancer progression by regulating miRNA-20b-3p/glutathione S-transferase mu 5 axis. World J Gastroenterol 2021; 27(36): 6064-6078
- URL: https://www.wjgnet.com/1007-9327/full/v27/i36/6064.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i36.6064